Association of the apolipoprotein A-IV: 360 Gln/His polymorphism with cerebrovascular disease, obesity, and depression in a Brazilian elderly population

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 135 B, Issue 1, 2005, Pages 65-68

  Ejchel, T F ^a   Araujo L M Q ^a   Ramos, L R ^a   Cendoroglo, M S ^a   De Smith, Marília Arruda Cardoso ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

APOA IV: 360 polymorphism; Apolipoprotein A IV; Elderly population; Morbidities

Indexed keywords

AGED; ALLELE; APOA IV GENE; ARTICLE; BRAZIL; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEPRESSION; DNA ISOLATION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALLELES; AMINO ACID SUBSTITUTION; APOLIPOPROTEINS A; BRAZIL; CEREBROVASCULAR DISORDERS; DEPRESSIVE DISORDER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; OBESITY; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 17744395713     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30175     Document Type: Article

References (39)

1. Bertolucci PF, Brucki SD, Campacci SR, Juliano Y. 1994a. The mini-mental state examination in a general population: impact of educational status. Arq Neurops 52:1-7.
2. Bertolucci PHF, Okamoto IH, Ramos LR, Toniolo Neto J, Brucki SMD. 1994b. Consortium to establish a registry for Alzheimer's disease. II: Bateria neuropsicologica. Arq de Neuro-psiqu 52(Suppl):101.
3. Blay S, Ramos LR, Mari J. 1988. Validity of a Brazilian version of the older americans resources and services (OARS) mental health screening questionaire. J Am Geriat Soc 36:687-692.
4. Bourre JM, Piciotti M, Dumont O. 1990. Delta 6 desaturase in brain and liver during development and aging. Lipids 25:354-356.
5. Bush TL, Miller SR, Golden AL, Hale WE. 1989. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health 79:1554-1556.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al. 2003. Seventh report of the Joint National Committee on: prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206-1252.
7. Clifton P, Kind K, Jones C, Noakes M. 1997. Response to dietary fat and cholesterol and genetic polymorphisms. Clin Exp Pharmacol Physiol 24:A21-A25.
8. DECODE study group. 1999. Glucose tolerance and mortality comparison of WHO and American diabetes association diagnostic criteria. Lancet 354:617-621.
9. Demeester N, Castro G, Desrumaux C, De Geitere C, Fruchart JC, Santens P et al. 2000. Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin: Cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease. J Lipid Res 41:963-974.
10. Duverger N, Tremp G, Caillaud JM, Emmanuel F, Castro G, Fruchart JC, Steinmetz A, Denefle P. 1996. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 273:966-968.
11. Eichner JE, Kuller LH, Ferrell RE, Kamboh MI. 1989. Phenotypic effects of apolipoprotein structural variation on lipid profiles. II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet Epidemiol 6:493-499.
12. Emery AEH. 1986. Methodology in Medical Genetics-an introduction to statistical methods. Edinburgh: Longman Group Ltd. p 197.
13. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. 2001. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 85(19):2486-2497.
14. Fiengenbaum M, Hutz M. 2003. Further evidence for the association between obesity-related traits and the apolipoprotein A-IV gene. Int J Obes Relat Metab Disord 27:484-490.
15. Gambert P, Lagrost L, Athias A, Bastiras S, Lallemant C. 1988. Role of apolipoprotein A-IV in the interconversion of HDL subclasses. Adv Exp Med Biol 243:263-269.
16. Heilbronn LK, Noakes M, Morris AM, Kind KL, Clifton PM. 2000. 360 His polymorphism of the apolipoprotein A-IV gene and plasma lipid response to energy restricted diets in overweight subjects. Atherosclerosis 150: 187-192.
17. Hixson JE, Vernier DT. 1991. Restriction isotyping of human apolipoprotein A-IV: Rapid typing of known isoforms and detection of a new isoform that deletes a conserved repeat. J Lipid Res 32:1529-1535.
18. Horrobin DF, Bennett CN. 1999. Depression and bipolar disorder: Relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, aging, and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 60:217-234.
19. Koch S, Donarski N, Goetze K, Kreckel M, Stuerenburg HJ, Buhmann C, Beisiegel U. 2001. Characterization of four lipoprotein classes in human cerebrospinal fluid. J Lipid Res 42:1143-1151.
20. Kyle UG, Genton L, Karsegard DHV, Michel J-P, Slosman DO, Pichard C. 2001. Total body mass, fat mass, fat-free mass, and skeletal differences in 60-year-old persons. J Am Geriat Soc 49:1633-1640.
21. Lahiri DK, Nurnberger JI. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
22. Lipschitz DA. 1994. Screening for nutritional status in the elderly. Prim Care 21(1):55-66.
23. Lohse P, Kindt MR, Rader DJ, Brewer HB Jr. 1990. Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J Biol Chem 265:10061-10064.
24. Merehed A, Xia Y, Papadopoulou A, Siest G, Visvikis S. 1998. Apolipoprotein AIV codon 360 mutation increases with human aging and is not associated with Alzheimer's disease. Neurosci Lett 242:117-119.
25. Ordovas JM, Cassidy DK, Civeira F, Bisgaier CL, Sehaefer EJ. 1989. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J Biol Chera 264(28):16339-16342.
26. Otha T, Fidge NH, Nestel PJ. 1985. Studies on the in vivo and in vitro distribution of apolipoprotein A-IV in human plasma and lymph. J Clin Invest 76:1252-1260.
27. Peelman F, Vinaimont N, Verhee A, Vanloo B, Verscheide JL, Labeur C et al. 1998. A proposed architecture for lecithin cholesterol acyl transferase (LCAT): Identification of the catalytic triad and molecular modeling. Protein Sci 7:587-599.
28. Pepe G, Di Perna V, Resta F, Lovecchio M, Chimienti G, Colacicco AM, Capurso A. 1998. In search of a biological pattern for human longevity: Impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians. Atherosclerosis 137:407-417.
29. Ramos LR, Toniolo NJ, Cendoroglo MS, Garcia JT, Najas MS, Perracini M et al. 1998. Two-year follow-up study of elderly residents in S. Paulo, Brazil: Methodology and preliminary results. Rev Saude Publics 32: 397-407.
30. Rewers M, Kamboh MI, Hoag S, Shetterly SM, Ferrell RE, Hamman RF. 1994. APOA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis valley diabetes study. Diabetes 43:1485-1489.
31. Rolland-Cachera MF, Cole TJ, Sempé M, Tichet JR, Rossignol C, Charraud A. 1991. Body mass index variations: Gentiles from birth to 97 years. Eur J Clin Nutri 45:13-21.
32. Steinmetz A, Utermann G. 1985. Activation of lecithin: Cholesterol aeyltransferase by human apolipoprotein A-IV. J Biol Chem 260:2258-2264.
33. Tenkanen H. 1989. Genotyping of apolipoprotein A-IV by digestion of amplified DNA with restriction endonuelease Fnu4H1: Use of tailored primer to abolish additional recognition sites during the gene amplification. J Lipid Res 30:545-549.
34. The expert committee on the diagnosis and classification of diabetes mellitus. 1997. Report of the expert committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Core 20:90-96.
35. Tombaugh TN, McIntyre NJ. 1992. The mini-mental state examination: A comprehensive review. J Am Geriat Soc 40:922-935.
36. Tso P, Liu M, Kalogeris TJ, Thomson AB. 2001. The role of apolipoprotein A-IV in the regulation of food intake. Annu Rev Nutr 21:231-254.
37. Warden CH, Langner CA, Gordon JI, Taylor BA, McLean JW, Lusis AJ. 1989. Tissue-specific expression, developmental regulation, and chromosomal mapping of the lecithin: Cholesterol acyltransferase gene. Evidence for expression in brain and testes as well as liver. J Biol Chem 264:21573-21581.
38. Weinberg RB, Dantzker C, Patton CS. 1990. Sensitivity of serum apolipoprotein A-IV levels to changes in dietary fat content. Gastroenterology 98:17-24
39. WHO/ISH writing group. 2003. WHO/ISH, World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertension 21:1983-1992.